Grant round · GrantConnect grant opportunity
Grant round GO6227
Awards in this round describe their activity in more than one way. The most common:
- “A Phase III Randomized Controlled Trial to evaluate the effectiveness of allogeneic adipose-derived mesenchymal stem cells for knee osteoarthritis” (1 award)
- “Accelerated drug discovery using population wide screening of patient iPSC’s for MND” (1 award)
- “Enabling new restorative treatments for spinal cord injury: a clinical trial of autologous olfactory cell nerve bridge transplantation in combination with intensive long-term rehabilitation” (1 award)
- “POPSTEM: Patient-specific cardiac stem cell villages for personalised therapeutic design” (1 award)
- “Spider venom peptides: precision therapy for genetic epilepsies” (1 award)
$35m
whole-of-term value of 6 awards to 6 named recipients, published 2024-09-23 to 2024-09-23
$7.1m falls in 2026-27, from 6 active awards. estimate: annualised
A grant round is a grant opportunity on GrantConnect: an open or targeted call for applications under published guidelines. GrantConnect’s award lists give the opportunity’s ID but not its title; search GrantConnect for GO6227 to read its guidelines.
By agency
| Granting agency | Awards | Total value |
|---|---|---|
| Department of Health and Aged Care | 5 | $30m |
| Department of Health, Disability and Ageing | 1 | $5.0m |
Recipients, largest first
Recipients who are individuals, and awards that name no single recipient, are counted above but not listed, here or in the CSV. Why The bulk download has every award, with individuals flagged.
| Recipient | Awards | Total value |
|---|---|---|
| Magellan Stem Cells | 1 | $7.7m |
| Griffith University | 1 | $6.8m |
| University of Melbourne | 1 | $6.5m |
| University of New South Wales | 1 | $5.0m |
| Flinders University | 1 | $5.0m |
| The University of Queensland | 1 | $4.2m |